Azelis Group NV is an investment holding company engaged in the provision of services relating to the specialty chemicals and food ingredients industry. The company is headquartered in Berchem, Antwerpen and currently employs 4,321 full-time employees. The company went IPO on 2021-09-17. The firm focuses on the intensified efforts for formulation work and application that supports the partners from the labs. The company works with Business to Business (B2B) buyers in the digital tools investment and technologies using online portals to find information on sellers, products, and services. The firm acts as an intermediary between suppliers of specialty chemicals or food ingredients who have entrusted it with several mandates to distribute their products, and its customers who serve the diversified markets of life sciences or industrial chemicals.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
4,110
4,110
4,214
4,152
4,109
2,827
Revenue Growth (YoY)
-2%
-2%
1%
1%
45%
27%
Cost of Revenue
3,164
3,164
3,206
3,191
3,164
2,185
Gross Profit
946
946
1,007
960
944
641
Selling, General & Admin
319
429
423
401
384
301
Research & Development
--
--
--
--
--
--
Operating Expenses
631
631
617
567
547
414
Other Non Operating Income (Expenses)
-27
-27
-32
-24
-13
-2
Pretax Income
175
175
256
247
314
120
Income Tax Expense
61
61
66
57
95
49
Net Income
111
111
180
177
213
67
Net Income Growth
-38%
-38%
2%
-17%
218%
-4%
Shares Outstanding (Diluted)
241.85
243.79
243.77
240.1
233.91
233.84
Shares Change (YoY)
-1%
0%
2%
3%
0%
0%
EPS (Diluted)
0.45
0.45
0.74
0.74
0.91
0.28
EPS Growth
-39%
-38%
0%
-19%
214%
-5%
Free Cash Flow
396
396
309
509
350
71
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
23.01%
23.01%
23.89%
23.12%
22.97%
22.67%
Operating Margin
7.66%
7.66%
9.23%
9.44%
9.66%
7.99%
Profit Margin
2.7%
2.7%
4.27%
4.26%
5.18%
2.37%
Free Cash Flow Margin
9.63%
9.63%
7.33%
12.25%
8.51%
2.51%
EBITDA
442
442
503
493
481
285
EBITDA Margin
10.75%
10.75%
11.93%
11.87%
11.7%
10.08%
D&A For EBITDA
127
127
114
101
84
59
EBIT
315
315
389
392
397
226
EBIT Margin
7.66%
7.66%
9.23%
9.44%
9.66%
7.99%
Effective Tax Rate
34.85%
34.85%
25.78%
23.07%
30.25%
40.83%
Follow-Up Questions
What are Azelis Group NV's key financial statements?
According to the latest financial statement (Form-10K), Azelis Group NV has a total asset of $5,406, Net profit of $111
What are the key financial ratios for AZLGY?
Azelis Group NV's Current ratio is 1.99, has a Net margin is 2.7, sales per share of $16.85.
How is Azelis Group NV's revenue broken down by segment or geography?
Azelis Group NV largest revenue segment is Life Sciences, at a revenue of 2,653,493,000 in the most earnings release.For geography, Rest of EMEA is the primary market for Azelis Group NV, at a revenue of 1,693,207,000.
Is Azelis Group NV profitable?
yes, according to the latest financial statements, Azelis Group NV has a net profit of $111
Does Azelis Group NV have any liabilities?
yes, Azelis Group NV has liability of 2,712
How many outstanding shares for Azelis Group NV?
Azelis Group NV has a total outstanding shares of 243.92